Mechanism of intranasal drug delivery directly to the brain

Crowe, Tyler P., Greenlee, M. Heather West, Kanthasamy, Anumantha G., Hsu, Walter H.·2018·Life Sciences

Cited by (721)

Items 201–300 of 721

  1. Prior nasal delivery of antagomiR-122 prevents radiation-induced brain injury
    Haihong Zhou, Fu-Rong Sun, Mingqian Ou, Yu Zhang, Meijun Lin, Liqin Song, Yangsheng Yu, Haojie Liao, Weihao Fan, Huaijie Xing et al. · 2021 · Molecular Therapy
  2. Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery
    Pauline E. M. van Schaik, Inge S. Zuhorn, Wia Baron · 2022 · International Journal of Molecular Sciences
  3. Intranasal Methylprednisolone Effectively Reduces Neuroinflammation in Mice With Experimental Autoimmune Encephalitis
    Dunia Rassy, Brandon Bárcena, Ivan Nicolás Pérez‐Osorio, Alejandro Espinosa, Alberto N. Peón, Luis Ignacio Terrazas, Gabriela Meneses, Hugo O. Besedovsky, Gladis Fragoso, Edda Sciutto · 2019 · Journal of Neuropathology & Experimental Neurology
  4. Intranasal delivery of engineered extracellular vesicles promotes neurofunctional recovery in traumatic brain injury
    Pengtao Li, Sishuai Sun, Xingyu Zhu, Xiaoyu Liu, Rui Ming Yin, Yi‐Hao Chen, Jianbo Chang, Liguo Ye, Jingxi Gao, Xiaoyan Zhao et al. · 2025 · Journal of Nanobiotechnology
  5. Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition
    Bapi Gorain, Davinaa C. Rajeswary, Manisha Pandey, Prashant Kesharwani, Santosh Ashok Kumbhar, Hira Choudhury · 2020 · Current Pharmaceutical Design
  6. Nanostructured Lipid Carriers for Nose to Brain Delivery Targeting CNS: Diversified Role of Liquid Lipids for Synergistic Action
    Avinash Ramrao Tekade, Pradeep Sadanand Mittha, Charushila Sopan Pisal · 2021 · Advanced Pharmaceutical Bulletin
  7. Cadmium neurotoxicity and therapeutic strategies
    Shuangquan Wen, Liang Wang · 2024 · Journal of Biochemical and Molecular Toxicology
  8. Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation
    Laura Tiozzo Fasiolo, Michele Dario Manniello, Sabrina Banella, Laura Napoli, Fabrizio Bortolotti, Eride Quarta, Paolo Colombo, Evangelos Balafas, Nikolaos G Kostomitsopoulos, Dimitrios M. Rekkas et al. · 2021 · International Journal of Pharmaceutics
  9. Protective Effects of Intranasally Administrated Oxytocin-Loaded Nanoparticles on Pentylenetetrazole-Kindling Epilepsy in Terms of Seizure Severity, Memory, Neurogenesis, and Neuronal Damage
    Hakan Sahin, Oğuz Yücel, Serkan Emik, Gözde Erkanlı Şentürk · 2022 · ACS Chemical Neuroscience
  10. Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood–Brain Barrier Disruption
    Charlotte Bérard, Stéphane Desgranges, Noé Dumas, Anthony Novell, Benoît Larrat, Mourad Hamimed, Nicolas Taulier, Marie‐Anne Estève, Florian Corréard, Christine Contino-Pepin · 2022 · Pharmaceutics
  11. Biodistribution and Respiratory Toxicity of Chloromethylisothiazolinone/Methylisothiazolinone Following Intranasal and Intratracheal Administration
    Mi‐Kyung Song, Jung Eun Park, Seung‐Hun Ryu, Yong-Wook Baek, Young‐Hee Kim, Dong Im Kim, Sung-Hoon Yoon, Hyun-Il Shin, Jongho Jeon, Kyuhong Lee · 2022 · Environment International
  12. Nose-to-brain co-delivery of repurposed simvastatin and BDNF synergistically attenuates LPS-induced neuroinflammation
    Dharani Manickavasagam, Li Lin, Moses O. Oyewumi · 2019 · Nanomedicine Nanotechnology Biology and Medicine
  13. Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
    Lauren Arms, Ryan J. Duchatel, Evangeline R. Jackson, Pedro Garcia Sobrinho, Matthew D. Dun, Susan Hua · 2024 · Journal of Controlled Release
  14. An Overview of Nanomedicines for Neuron Targeting
    Jesús García-Chica, West Kristian D. Paraiso, Shihori Tanabe, Dolors Serra, Laura Herrero, Núria Casals, Jordi García, Xavier Ariza, Sabina Quader, Rosalía Rodríguez‐Rodríguez · 2020 · Nanomedicine
  15. Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies
    Helena Domin · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  16. The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline
    Péter Gieszinger, T. Kiss, Piroska Szabó‐Révész, Rita Ambrus · 2021 · Pharmaceutics
  17. Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a promising platform for nose to brain delivery: Preparation, in vitro optimization, ex vivo cytotoxicity & in vivo biodistribution utilizing radioiodinated zopiclone
    Esraa Taha, Samia Abd El-Kader Nour, Wael Mamdouh, Adli A. Selim, Mohamed M. Swidan, Ahmed B. Ibrahim, Marianne Joseph Naguib · 2023 · International Journal of Pharmaceutics X
  18. The prescription design and key properties of nasal gel for CNS drug delivery: A review
    Miao Wang, Xinyu Ma, Shiyu Zong, Yaqiong Su, Rui Su, Hong Zhang, Yang Liu, Chunliu Wang, Ye Li · 2023 · European Journal of Pharmaceutical Sciences
  19. Nose-to-brain Delivery of Biologics
    Bettina Schwarz, Olivia M. Merkel · 2019 · Therapeutic Delivery
  20. Intranasal Insulin: a Treatment Strategy for Addiction
    Bhavani Kashyap, Leah R. Hanson, William H. Frey · 2020 · Neurotherapeutics
  21. Brain targeted delivery of lurasidone HCl via nasal administration of mucoadhesive nanoemulsion formulation for the potential management of schizophrenia
    Mrunali Rashmin Patel, Rashmin B. Patel, Shivam D. Thakore, Ajay B. Solanki · 2020 · Pharmaceutical Development and Technology
  22. Comparative evaluation of intranasally delivered quetiapine loaded mucoadhesive microemulsion and polymeric nanoparticles for brain targeting: pharmacokinetic and gamma scintigraphy studies
    Brijesh M. Shah, Dignesh Khunt, Manju Misra · 2021 · Future Journal of Pharmaceutical Sciences
  23. Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System
    Jinxiu Li, Qian Xie, Rong Ma, Yong Li, Jianmei Yuan, Mihong Ren, Hongyan Li, Jiajun Wang, Danni Lu, Zhuo Xu et al. · 2021 · Frontiers in Medicine
  24. Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources
    F. Vela, Abdellah Ezzanad, A. Hunter, A. Macías-Sánchez, R. Hernández-Galán · 2022 · Pharmaceuticals
  25. Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Diseases
    Emmanuel Broni, Andrew Striegel, Carolyn N. Ashley, Patrick Opare Sakyi, Saqib Peracha, Miriam Velazquez, Kristeen Bebla, Monsheel Sodhi, Samuel K. Kwofie, Adesanya Ademokunwa et al. · 2023 · International Journal of Molecular Sciences
  26. Bi-functional sterically hindered phenol lipid-based delivery systems as potential multi-target agents against Alzheimer's disease via an intranasal route
    Evgenia A. Burilova, Tatiana N. Pashirova, Irina V. Zueva, Э. М. Гибадуллина, Sofya V. Lushchekina, Аnastasiia S. Sapunova, Ramilya M. Kayumova, A.M. Rogov, Vladimir G. Evtugyn, Igor A. Sudakov et al. · 2020 · Nanoscale
  27. Hyaluronic Acid Scaffolds for Loco-Regional Therapy in Nervous System Related Disorders
    Amel Djoudi, Rodolfo Molina-Peña, Natália Helen Ferreira, Ilaria Ottonelli, Giovanni Tosi, Emmanuel Garcion, Frank Boury · 2022 · International Journal of Molecular Sciences
  28. Multiple CEST contrast imaging of nose-to-brain drug delivery using iohexol liposomes at 3T MRI
    Lok Hin Law, Jianpan Huang, Peng Xiao, Yang Liu, Zilin Chen, Joseph H. C. Lai, Xiongqi Han, Gerald Wai‐Yeung Cheng, Kai‐Hei Tse, Kannie W. Y. Chan · 2023 · Journal of Controlled Release
  29. Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs
    Jéssica L. Antunes, Joana Amado, Francisco Veiga, Ana Cláudia Paiva‐Santos, Patrícia C. Pires · 2023 · Pharmaceutics
  30. Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis
    Ariane Mwema, Giulio G. Muccioli, Anne des Rieux · 2023 · Journal of Controlled Release
  31. Advanced nanoparticle strategies for optimizing RNA therapeutic delivery in neurodegenerative disorders
    Narges Naimi, Homa Seyedmirzaei, Zahra Hassannejad, Alireza Soltani Khaboushan · 2024 · Biomedicine & Pharmacotherapy
  32. Furan-Derived Lipid Nanoparticles for Transporting mRNA to the Central Nervous System
    Zhengwei Liu, Yuebao Zhang, Haoyuan Li, Kaiyuan Guo, Meng Tian, Dinglingge Cao, Diana D. Kang, Yonger Xue, Xucheng Hou, Chang Wang et al. · 2025 · Journal of the American Chemical Society
  33. Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration
    Huanhuan Wu, Chenyu Li, Hong Yuan, Jingyuan Zhao, Shuai Li · 2025 · International Journal of Nanomedicine
  34. Microemulsion as a promising carrier for nose to brain delivery: journey since last decade
    Brijesh M. Shah · 2021 · Journal of Pharmaceutical Investigation
  35. Intranasal Paclitaxel Alters Alzheimer’s Disease Phenotypic Features in 3xTg-AD Mice
    Donna J. Cross, Bertrand R. Huber, Michael A. Silverman, Marcella M. Cline, Trevor B. Gill, Chloe G. Cross, David G. Cook, Satoshi Minoshima · 2021 · Journal of Alzheimer s Disease
  36. High-mobility group box 1-mediated hippocampal microglial activation induces cognitive impairment in mice with neuropathic pain
    Kazue Hisaoka‐Nakashima, Kazuto Ohata, Natsuki Yoshimoto, Shintarou Tokuda, Nanako Yoshii, Yoki Nakamura, Dengli Wang, Keyue Liu, Hidenori Wake, Takayuki Yoshida et al. · 2022 · Experimental Neurology
  37. Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders
    Natalia Villar-Gómez, Doddy Denise Ojeda-Hernández, Eneritz López-Muguruza, Silvia García-Flores, Natalia Bonel-García, María Soledad Benito‐Martín, Belén Selma-Calvo, Alejandro Arturo Canales-Aguirre, Juan Carlos Mateos‐Díaz, Paloma Montero‐Escribano et al. · 2022 · Cells
  38. Polymeric nanoparticles for efficient nose-to-brain delivery
    Marie Bolon, M. Fieux, Claire Monge, Sophie Richard · 2025 · Nanoscale
  39. Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062, a prodrug of galantamine
    Charlotte Bakker, Jasper van der Aart, Ellen P. Hart, Erica Surya Klaassen, Kirsten Riber Bergmann, Michiel Joost van Esdonk, Denis George Kay, Geert Jan Groeneveld · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  40. Intranasal delivery of lipid-based nanosystems as a promising approach for brain targeting of the new-generation antiepileptic drug perampanel
    Sara Meirinho, Márcio Rodrigues, Catarina L. Ferreira, Rui Caetano Oliveira, Ana C. Fortuna, Adriana O. Santos, Amílcar C. Falcão, Gilberto Alves · 2022 · International Journal of Pharmaceutics
  41. Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose–Brain Drug Delivery
    Esraa Taha, Amro Shetta, Samia Abd El-Kader Nour, Marianne Joseph Naguib, Wael Mamdouh · 2024 · Molecular Pharmaceutics
  42. Intranasal Subunit Vaccination Strategies Employing Nanomaterials and Biomaterials
    Benjamin James Cossette, Sean H. Kelly, Joel H. Collier · 2020 · ACS Biomaterials Science & Engineering
  43. Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place?
    Giacomo Giacovazzo, Tiziana Bisogno, Fabiana Piscitelli, Roberta Verde, Sergio Oddi, Mauro Maccarrone, Roberto Coccurello · 2019 · International Journal of Molecular Sciences
  44. Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats
    Deborah Dhuyvetter, Fetene B. Tekle, Maxim Nazarov, Rob J. Vreeken, Herman Borghys, Frederik J. R. Rombouts, Ilse Lenaerts, Astrid Bottelbergs · 2020 · Drug Delivery
  45. Stem Cell-derived Extracellular Vesicles: A Promising Nano Delivery Platform to the Brain?
    Yuying Guo, Dongsheng Hu, Lu Lian, Linna Zhao, Mingli Li, Huijing Bao, Shixin Xu · 2022 · Stem Cell Reviews and Reports
  46. Intranasal Administration as a Route to Deliver Drugs to the Brain (Review)
    Natalia N. Porfiryeva, Сёмина Ирина Ивановна, Rouslan I. Moustafine, Vitaliy V. Khutoryanskiy · 2021 · Drug development & registration
  47. Unravelling Micro and Nano Vesicular System in Intranasal Drug Delivery for Epilepsy
    Sagar Salave, Dhwani Rana, Rupali Pardhe, Prajakta Bule, Derajram M. Benival · 2022 · Pharmaceutical Nanotechnology
  48. Erinacine A attenuates glutamate transporter 1 downregulation and protects against ischemic brain injury
    Pei-Chien Hsu, Yi-Jie Lan, Chin‐Chu Chen, Li‐Ya Lee, Wan-Ping Chen, Yun-Ching Wang, Yi‐Hsuan Lee · 2022 · Life Sciences
  49. Investigation of the “Nose-to-Brain” Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability
    Yueyao Jiang, Yichuan Jiang, Zhiying Ding, Qian Yu · 2022 · International Journal of Nanomedicine
  50. Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action
    Wade M. Cooper, Sutapa Ray, Sheena K. Aurora, Stephen Bevan Shrewsbury, Christopher Fuller, Greg Davies, John Hoekman · 2022 · Journal of Aerosol Medicine and Pulmonary Drug Delivery
  51. Simultaneous Intranasal Codelivery of Donepezil and Memantine in a Nanocolloidal Carrier: Optimization, Pharmacokinetics, and Pharmacodynamics Studies.
    Mayank Handa, S. N. Sanap, R. Bhatta, G. P. Patil, Rajendra Palkhade, D. P. Singh, R. Shukla · 2023 · Molecular Pharmaceutics
  52. In situ-gelling hydrophobized starch nanoparticle-based nanoparticle network hydrogels for the effective delivery of intranasal olanzapine to treat brain disorders
    Andrew Lofts, Matthew A. Campea, Erica Winterhelt, Nicolette Rigg, Nahieli Preciado Rivera, Cameron Macdonald, Benicio Noronha Frey, Ram K. Mishra, Todd R. Hoare · 2024 · International Journal of Biological Macromolecules
  53. Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of Alzheimer’s disease
    Sara Chavoshinezhad, Homa Mohseni Kouchesfahani, Mohammad Saied Salehi, Sareh Pandamooz, Abolhassan Ahmadiani, Leila Dargahi · 2019 · Brain Research Bulletin
  54. Enhanced Nano-Vaccine Utilizing Biomineralized Virus-like Particles for Efficient Glioblastoma Immunotherapy via the Nose-To-Brain Delivery Pathway
    Chufan Wang, Wei Jie Feng, Jian Li, Jiaping Wang, Lifen Liu, Shanghui Ye, Yuhao Zhang, Jiaxin Fu, Haiping Zheng, E. Chen et al. · 2025 · ACS Nano
  55. Intranasal Dexmedetomidine Reduces Postoperative Opioid Requirement in Patients Undergoing Total Knee Arthroplasty Under General Anesthesia
    Suvi‐Maria Tiainen, Ronja Kuuskoski, Keijo T Mäkelä, Teijo I. Saari, Panu Uusalo · 2020 · The Journal of Arthroplasty
  56. Designing nanoformulation for the nose‐to‐brain delivery in Parkinson's disease: Advancements and barrier
    Pallavi Kiran, Sujit Kumar Debnath, Suditi Neekhra, Vaishali Satyajeet Pawar, Amreen Khan, Faith Dias, Shubham Pallod, Rohit Srivastava · 2021 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  57. Nasal route for antibiotics delivery: Advances, challenges and future opportunities applying the quality by design concepts
    Sandra Aulia Mardikasari, Bence Sipos, Ildikó Csóka, Gábor Katona · 2022 · Journal of Drug Delivery Science and Technology
  58. Formulation strategies for nose-to-brain drug delivery in Alzheimer's disease
    Manisha Vohra, Mohammad Amir, Amit Sharma, Sheetu Wadhwa · 2023 · Health Sciences Review
  59. Nose-to-Brain delivery of donepezil hydrochloride following administration of an HPMC-Me-β-CD-PEG400 nasal film in mice
    Paraskevi Papakyriakopoulou, Evangelos Balafas, Gaia Colombo, Dimitrios M. Rekkas, Nikolaos G Kostomitsopoulos, Georgia N. Valsami · 2023 · Journal of Drug Delivery Science and Technology
  60. IFNγ-stimulated dendritic cell extracellular vesicles can be nasally administered to the brain and enter oligodendrocytes
    Kae M. Pusic, Richard P. Kraig, Aya D. Pusic · 2021 · PLoS ONE
  61. Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration
    Ekta Kadakia, Dean C. Bottino, Mansoor M. Amiji · 2019 · Pharmaceutical Research
  62. Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐specific pathway of functional neurologic improvement
    Jared M. Fine, Jacob Kosyakovsky, Amanda M. Baillargeon, Julian V. Tokarev, Jacob M. Cooner, Aleta L. Svitak, Katherine A. Faltesek, William H. Frey, Leah R. Hanson · 2020 · Brain and Behavior
  63. NOSE-TO-BRAIN DRUG DELIVERY: AN UPDATE TO THE ALTERNATIVE PATH TO SUCCESSFUL TARGETED ANTI-MIGRAINE DRUGS
    Souvik Chattopadhyay, Sujit Das, KOUSHIK NARAYAN SARMA · 2021 · International Journal of Applied Pharmaceutics
  64. Overcoming Blood-Brain Barrier Resistance: Implications for Extracellular Vesicle-Mediated Drug Brain Delivery
    Jean Paul Dardet, Nelson Serrano, Ibolya Edit Andras, Michal J. Toborek · 2022 · Frontiers in Drug Delivery
  65. Biomaterials Comprising Implantable and Dermal Drug Delivery Targeting Brain in Management of Alzheimer’s Disease: A Review
    Neelakanta Sarvashiva Kiran, Gorthi Vaishnavi, Sudarshan Kumar Singh, Chandrashekar Yashaswini, Akshay Parihar, Swati Pal, Jasveer Kaur, Bhupendra Gopalbhai Prajapati, Popat B Mohite, Abhijeet Vishnu Puri · 2024 · Regenerative Engineering and Translational Medicine
  66. Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease
    Sasivimol Virameteekul, Andrew John Lees, Roongroj Bhidayasiri · 2024 · Movement Disorders
  67. Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration
    Joana Gonçalves, Gilberto Alves, Andreia Carona, Joana Bicker, Carla Vitorino, Amílcar C. Falcão, Ana C. Fortuna · 2020 · Pharmaceutical Research
  68. Biomimetic Nanoparticles Enhance Recovery of Movement Disorders in Parkinson’s Disease by Improving Microglial Mitochondrial Homeostasis and Suppressing Neuroinflammation
    Liang Li, Chunbin Sun, Shanglin Cai, Zhongci Hang, Xiaoyu Gao, Liangxuan Hou, Luping Li, Yawen Wu, Cencan Xing, Hongwu Du · 2025 · ACS Applied Materials & Interfaces
  69. Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery
    Anisha A. D’souza, Valentina Di Francesco, Alicia Yang, Benjamin Saul Bleier, Mansoor M. Amiji · 2025 · Expert Opinion on Drug Delivery
  70. Cargo‐Templated Crosslinked Polymer Nanocapsules and Their Biomedical Applications
    Yu Zhao, Qiushi Li, Jingshan Chai, Yang Liu · 2021 · Advanced NanoBiomed Research
  71. Neuroprotection by resveratrol: A review on brain delivery strategies for Alzheimer's and Parkinson's disease
    Vasanthi Chinraj, R. Sureshkumar · 2022 · Journal of Applied Pharmaceutical Science
  72. Intranasal dexmedetomidine in healthy beagles: An echocardiographic and pharmacokinetic/pharmacodynamic study
    Bruna Santangelo, Mathieu Harel, I. Fourel, Fabiana Micieli, Mauro Cataldi, Émilie Ségard-Weisse, Karine Portier · 2019 · The Veterinary Journal
  73. Preparation and characterization of lamotrigine containing nanocapsules for nasal administration
    Péter Gieszinger, Nœmi Csaba, Marcos García-Fuentes, Maruthi Prasanna, Róbert Gáspár, Anita Sztojkov‐Ivanov, Eszter Ducza, Árpád Márki, Tamás Janáky, Gábor Kecskeméti et al. · 2020 · European Journal of Pharmaceutics and Biopharmaceutics
  74. Patient-Friendly, Olfactory-Targeted, Stimuli-Responsive Hydrogels for Cerebral Degenerative Disorders Ensured > 400% Brain Targeting Efficiency in Rats
    Noha Adel Nafee, Abd El Rahman Ameen, Ossama Y. Abdallah · 2020 · AAPS PharmSciTech
  75. Mechanistic research and therapeutic prospects of alternative splicing in neurodegenerative diseases
    Xiaolan Ran, Mei Wang, Juan Huang, Nanyu Kuang, Peng Tian, Jingjing Wu, Fei Feng, Yong Luo, Nanqu Huang · 2026 · Ageing Research Reviews
  76. Inhalation of Silver Silicate Nanoparticles Leads to Transient and Differential Microglial Activation in the Rodent Olfactory Bulb
    Ho Thi Thuy Huynh, Priya Upadhyay, Cora H. Lopez, Malia K. Miyashiro, Laura S. Van Winkle, Sara M. Thomasy, Kent E. Pinkerton · 2022 · Toxicologic Pathology
  77. Anti-interleukin-6 receptor antibody improves allodynia and cognitive impairment in mice with neuropathic pain following partial sciatic nerve ligation
    Kazue Hisaoka‐Nakashima, Kodai Moriwaki, Natsuki Yoshimoto, Toshiki Yoshii, Yoki Nakamura, Yukio Ago, Norimitsu Morioka · 2022 · International Immunopharmacology
  78. Intranasal Administration of N-acetyl-L-cysteine Combined with Cell-Penetrating Peptide-Modified Polymer Nanomicelles as a Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis
    Takumi Kurano, Takanori Kanazawa, Shingo Iioka, Hiromu Kondo, Yasuhiro Kosuge, Toyofumi Suzuki · 2022 · Pharmaceutics
  79. Mixed nut consumption improves brain insulin sensitivity: a randomized, single-blinded, controlled, crossover trial in older adults with overweight or obesity
    Kevin M.R. Nijssen, Ronald P. Mensink, Jogchum Plat, Dimo Ivanov, Hubert T. Preissl, Peter J. Joris · 2023 · American Journal of Clinical Nutrition
  80. Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer’s Disease: A Recent Update
    Manisha Pandey, Hira Choudhury, Rohit Kumar Verma, Viney Chawla, Subrat Kumar Bhattamisra, Bapi Gorain, Maria Abdul Ghafoor Raja, Muhammad Wahab Amjad · 2020 · CNS & Neurological Disorders - Drug Targets
  81. Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment
    Julio Mena-Hernández, Helgi Helene Jung-Cook, Monserrat Llaguno Munive, Patricia García‐López, Adriana Ganem‐Rondero, Simón López‐Ramírez, Fernando Barragán-Aroche, Marisol Rivera-Huerta, Lourdes Mayet-Cruz · 2020 · AAPS PharmSciTech
  82. Differential effects of the Piezo1 agonist Yoda1 in the trigeminovascular system: An electrophysiological and intravital microscopy study in rats
    Antonina Dolgorukova, Julia Isaeva, Elena V. Verbitskaya, Ольга Анатольевна Любашина, Rashid A. Giniatullin, Alexey Y. Sokolov · 2021 · Experimental Neurology
  83. Thermo-sensitive hydrogel and their biomedical applications
    Mengli Tian, Jin Feng Zhou, Xue‐Jie Qi, Rui Shen · 2021 · IOP Conference Series Earth and Environmental Science
  84. Brain Targeting and Toxicological Assessment of the Extracellular Vesicle-Packaged Antioxidant Catalase-SKL Following Intranasal Administration in Mice
    Sarah H. Hayes, Qingfan Liu, Sureka Selvakumaran, Matthew J. Haney, Elena V. Batrakova, Brian Leonard Allman, Paul A. Walton, Patti K. Kiser, Shawn Narain Whitehead · 2021 · Neurotoxicity Research
  85. Nose-to-Brain Drug Delivery
    Linh Thi-Thao Nguyen, Van‐An Duong · 2025 · Encyclopedia
  86. Characterization of anatomical variations of the nasal cavity in a subset of European patients and their impact on intranasal drug delivery
    Mike Pasteur, Guillaume Arsouze, Guy Ilango, Déborah Le Pennec, Dimitri Kulker, Anaïs Heyraud, Jean‐Philippe Cottier, Charles Aussedat, Nathalie Heuzé‐Vourc'h, Virginie Hervé et al. · 2024 · International Journal of Pharmaceutics
  87. Challenges and Opportunities for Incorporating Physiological Information into Pharmacokinetic Models of Intranasal Drug Delivery to the Brain: A Review of the Current Status and Future Trajectories
    Saeed Rezaee, Zubida M. Al‐Majdoub, Aleksandra Galetin, Amin Rostami‐Hodjegan, Kayode Ogungbenro · 2025 · Molecular Pharmaceutics
  88. Overcoming the Blood-Brain Barrier for Drug Delivery to the Brain
    Jennifer S. Katz, Hasan Slika, Shahab Aldin Sattari, Adarsha P. Malla, Yuanxuan Xia, Albert Antar, Kathleen Renee Ran, Betty Tyler · 2025 · ACS Omega
  89. Nanoemulsions and Microemulsions for Intranasal Drug Delivery: A Bibliometric Analysis and Emerging Trends (2004–2024)
    Ariane Krause Padilha Lorenzett, Vanderlei Aparecido de Lima, Clóvis Orlando Pereira da Fonseca, Rubiana Mara Mainardes · 2025 · Pharmaceutics
  90. Cubosomes: Novel Nanocarriers for Drug Delivery
    Brijesh Patel, Hetal Paresh Thakkar · 2021 · Springer eBooks
  91. FGF17 protects cerebral ischemia reperfusion-induced blood-brain barrier disruption via FGF receptor 3-mediated PI3K/AKT signaling pathway
    Wenting Huang, Xiong-Jian Chen, Yu-Kai Lin, Jun-Feng Shi, Hong Li, Hao-Di Wu, Ruo-Lin Jiang, Shuai Chen, Xue Bing Wang, Xianxi Tan et al. · 2024 · European Journal of Pharmacology
  92. Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy
    Qiankun Zhang, Songze Huang, Xiaowen Liu, Wei Wang, Zhihan Zhu, Lukui Chen · 2024 · International Journal of Nanomedicine
  93. Nervous system exposure of different classes of nanoparticles: A review on potential toxicity and mechanistic studies
    Mingyang Gao, Ziye Yang, Zhen Zhang, Liqun Chen, Baoshan Xu · 2024 · Environmental Research
  94. Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain Diseases
    Kaiting Miao, Xue Xia, Yan Zou, Bingyang Shi · 2024 · Molecular Pharmaceutics
  95. Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges
    Tanisha Tabassum Sayka Khan, Zara Sheikh, Simin D. Maleknia, Farshad Oveissi, Ali Fathi, Terence Abrams, Hui Xin Ong, Daniela Traini · 2024 · Expert Opinion on Drug Delivery
  96. An Update on Recent Drug Delivery Systems Targeting Brain Diseases via the Transnasal Pathway
    Huiying Zeng, Huangjie Lu, Jie Yang, Ping Hu · 2024 · Pharmaceutical Research
  97. Advances in mucoadhesive and mucus-penetrating materials, nano-formulations, and in situ gelling systems for nasal drug delivery
    Natalia N. Porfiryeva, Rouslan I. Moustafine, Vitaliy V. Khutoryanskiy · 2026 · Expert Opinion on Drug Delivery
  98. Characterization of Endogenous Telomerase-Positive Stem Cells for Regenerative Medicine, A Review
    Warren Young, Mark O Speight · 2020 · Stem Cell & Regenerative Medicine
  99. Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives
    Lucia Ya. Zakharova, Gulnara A. Gaynanova, Elmira A. Vasilieva, Leysan A. Vasileva, Rais V. Pavlov, Ruslan R. Kashapov, Konstantin A Petrov, Oleg Gerol'dovich Sinyashin · 2022 · Current Medicinal Chemistry
  100. Astrocytic aryl hydrocarbon receptor mediates chronic kidney disease‐associated mental disorders involving GLT1 hypofunction and neuronal activity enhancement in the mouse brain
    Yu‐Jie Huang, Chia‐Chi Hung, Pei-Chien Hsu, Po‐Yi Lee, Yen‐An Tsai, Yu‐Chiao Hsin, Xie‐Ting Lee, Chia‐Cheng Chou, Mei‐Lien Chen, Der‐Cherng Tarng et al. · 2022 · Glia